Enarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Term Trial.
依罗达司他治疗血液透析患者贫血的转换和维持治疗:一项随机、安慰剂对照的 2b 期试验及长期试验。
Nephron. 2019;143(2):77-85. doi: 10.1159/000500487. Epub 2019 May 22.